Balato A, Campione E, Cirillo T, et al. - Among 96 patients with psoriatic arthritis (PsA) and concomitant cutaneous psoriasis, researchers evaluated long‐term effectiveness, safety and tolerability of apremilast. Individuals attending 3 Italian University and Hospital centers, who received at least one dose of apremilast and had at least one follow‐up visit were involved in this real‐life retrospective observational study. This research confirms the efficacy and safety of apremilast on PsA's joints and skin involvement, highlighting which patients may have a less favorable response to treatment.